I. Kopp

6.4k total citations
125 papers, 2.1k citations indexed

About

I. Kopp is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and General Health Professions. According to data from OpenAlex, I. Kopp has authored 125 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Public Health, Environmental and Occupational Health, 44 papers in Economics and Econometrics and 36 papers in General Health Professions. Recurrent topics in I. Kopp's work include Clinical practice guidelines implementation (59 papers), Health Systems, Economic Evaluations, Quality of Life (42 papers) and Health and Medical Studies (20 papers). I. Kopp is often cited by papers focused on Clinical practice guidelines implementation (59 papers), Health Systems, Economic Evaluations, Quality of Life (42 papers) and Health and Medical Studies (20 papers). I. Kopp collaborates with scholars based in Germany, United States and Canada. I. Kopp's co-authors include Michael Koller, Monika Nothacker, Cathleen Muche‐Borowski, W. Lorenz, Markus Follmann, R. Kreienberg, A. Encke, Achim Wöckel, Μ. Rothmund and Holger J. Schünemann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Journal of Clinical Epidemiology.

In The Last Decade

I. Kopp

120 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Kopp Germany 24 555 533 376 351 351 125 2.1k
Kathryn Fitch United States 16 685 1.2× 322 0.6× 327 0.9× 566 1.6× 555 1.6× 33 2.6k
Thomas E. Elliott United States 20 688 1.2× 461 0.9× 405 1.1× 404 1.2× 193 0.5× 66 2.2k
Holger Gothe Germany 20 542 1.0× 269 0.5× 456 1.2× 502 1.4× 390 1.1× 70 2.4k
Kinwah Fung Canada 26 374 0.7× 460 0.9× 403 1.1× 377 1.1× 181 0.5× 103 2.8k
Derek Kyte United Kingdom 26 421 0.8× 361 0.7× 298 0.8× 427 1.2× 618 1.8× 70 2.3k
David Wonderling United Kingdom 25 270 0.5× 359 0.7× 753 2.0× 385 1.1× 724 2.1× 47 3.1k
Richard T. Meenan United States 26 250 0.5× 495 0.9× 243 0.6× 502 1.4× 434 1.2× 93 2.3k
Peter M. van de Ven Netherlands 30 380 0.7× 350 0.7× 545 1.4× 322 0.9× 179 0.5× 114 3.1k
Deborah Fitzsimmons United Kingdom 26 307 0.6× 724 1.4× 525 1.4× 232 0.7× 184 0.5× 88 2.2k
M. Rainfray France 25 364 0.7× 727 1.4× 478 1.3× 197 0.6× 417 1.2× 101 3.2k

Countries citing papers authored by I. Kopp

Since Specialization
Citations

This map shows the geographic impact of I. Kopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Kopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Kopp more than expected).

Fields of papers citing papers by I. Kopp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Kopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Kopp. The network helps show where I. Kopp may publish in the future.

Co-authorship network of co-authors of I. Kopp

This figure shows the co-authorship network connecting the top 25 collaborators of I. Kopp. A scholar is included among the top collaborators of I. Kopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Kopp. I. Kopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmucker, Christine, et al.. (2025). First Evidence-Based Guideline for Interventions in FASD. Neuropediatrics. 56(3). 160–171.
2.
Batool, Amna, I. Kopp, Manja Kubeil, et al.. (2025). Targeted bismuth-based materials for cancer. Dalton Transactions. 54(14). 5614–5639. 1 indexed citations
3.
Landgraf, Mirjam N., et al.. (2024). Diagnosis of fetal alcohol spectrum disorders: German guideline version 2024. European Journal of Paediatric Neurology. 53. 155–165. 1 indexed citations
4.
Krohn, Sebastian, I. Kopp, & Peter Proff. (2023). Der Stellenwert von Leitlinien in der Zahnheilkunde und in der zahnmedizinischen Ausbildung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 66(12). 1409–1413. 1 indexed citations
5.
Piggott, Thomas, Miranda Langendam, Elena Parmelli, et al.. (2022). The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development. Journal of Clinical Epidemiology. 154. 197–203. 6 indexed citations
6.
Nothacker, Monika, Katrin Arnold, Stefanie Deckert, et al.. (2021). International experiences in the development and implementation of guideline-based quality indicators: a qualitative study. BMJ Open. 11(1). e039770–e039770. 7 indexed citations
7.
Schünemann, Finn, Joerg J Meerpohl, Lukas Schwingshackl, I. Kopp, & Holger J. Schünemann. (2021). Guidelines 2.0: Systematische Entwicklung einer umfassenden Checkliste für eine vertrauenswürdige Leitlinienentwicklung. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 163. 76–84. 5 indexed citations
8.
Häuser, Winfried, Frank Petzke, I. Kopp, & Monika Nothacker. (2017). Der Einfluss von Interessenkonflikten auf Leitlinienempfehlungen. Der Schmerz. 31(3). 308–318. 4 indexed citations
9.
Nothacker, Monika, R. Kreienberg, & I. Kopp. (2017). „Gemeinsam Klug Entscheiden“ – eine Initiative der AWMF und ihrer Fachgesellschaften: Mission, Methodik und Anwendung. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 129. 3–11. 5 indexed citations
10.
Weberschock, Tobias, et al.. (2016). Verbindlichkeit von Empfehlungsformulierungen in Leitlinien: Survey zur Wahrnehmung unter Leitlinienentwicklern. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 113. 1–8. 3 indexed citations
11.
Röth, Andreas, Johannes Beckmann, K. Bohndorf, et al.. (2015). S3-Guideline non-traumatic adult femoral head necrosis. Archives of Orthopaedic and Trauma Surgery. 136(2). 165–174. 47 indexed citations
12.
Nothacker, Monika, Cathleen Muche‐Borowski, & I. Kopp. (2014). Guidelines in the Register of the Association of Scientific Medical Societies in Germany – A Quality Improvement Campaign. Geburtshilfe und Frauenheilkunde. 74(3). 260–266. 23 indexed citations
13.
Kreienberg, R., Ute‐Susann Albert, Markus Follmann, et al.. (2013). Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer. Geburtshilfe und Frauenheilkunde. 73(6). 556–583. 41 indexed citations
14.
Landgraf, Mirjam N., Monika Nothacker, I. Kopp, & Florian Heinen. (2013). The Diagnosis of Fetal Alcohol Syndrome. Deutsches Ärzteblatt international. 110(42). 703–10. 22 indexed citations
15.
Häuser, Winfried, et al.. (2012). Methodenreport zur Erstellung der Leitlinie. Der Schmerz. 26(3). 232–246. 18 indexed citations
16.
Pfennig, Andrea, Tom Bschor, Thomas C. Baghai, et al.. (2012). S3-Leitlinie zur Diagnostik und Therapie bipolarer Störungen. Der Nervenarzt. 83(5). 568–586. 47 indexed citations
17.
Weinbrenner, Susanne, et al.. (2010). 7 Jahre Nationale VersorgungsLeitlinien (NVL) - Quo vadis?. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 104(7). 533–539. 3 indexed citations
18.
Sommer, Claudia, Marcus Schiltenwolf, Martin Offenbächer, et al.. (2008). Management of fibromyalgia syndrome – an interdisciplinary evidence-based guideline. SHILAP Revista de lepidopterología. 22 indexed citations
19.
Kopp, I., et al.. (2005). Implementierung von Leitlinien in den Versorgungsalltag. 2(1). 33–38. 19 indexed citations
20.
Kopp, I., Wolfgang Müller, & W Lorenz. (2003). [In the balance: the central role of outcome in guidelines and disease management programs].. PubMed. 97(3). 233–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathryn Fitch Breakdown of academic impact, for papers by Thomas E. Elliott Breakdown of academic impact, for papers by Holger Gothe Breakdown of academic impact, for papers by Kinwah Fung Breakdown of academic impact, for papers by Derek Kyte Breakdown of academic impact, for papers by David Wonderling Breakdown of academic impact, for papers by Richard T. Meenan Breakdown of academic impact, for papers by Peter M. van de Ven Breakdown of academic impact, for papers by Deborah Fitzsimmons Breakdown of academic impact, for papers by M. Rainfray
Rankless by CCL
2026